Morgan Stanley »

Apellis Pharmaceuticals shares owned by Morgan Stanley

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-03-31 $96M 1.6M 58.78
2023-09-30 $61M 1.6M 38.04
2023-06-30 $69M 757k 91.10
2022-12-31 $16M 300k 51.71
2022-06-30 $20M 453k 44.44
2022-03-31 $13M 253k 50.81
2021-06-30 $15M 229k 63.21
2020-12-31 $5.7M 100k 57.19
2020-09-30 $1.2M 40k 30.19
2020-06-30 $1.8M 56k 32.65
2020-03-31 $1.3M 50k 26.79
2019-12-31 $3.8M 123k 30.62
2019-09-30 $9.9M 412k 24.09
2019-03-31 $24M 1.2M 19.50
2018-12-31 $747k 57k 13.19
2018-09-30 $1.1M 60k 17.77
2018-06-30 $1.8M 80k 22.00
2018-03-31 $453k 21k 22.10
2017-12-31 $410k 19k 21.68